肺癌放疗后急性呼吸困难严重程度的多项式NTCP模型的开发与内部验证
研究纳入182例接受根治性(放化疗)的I-IV期肺癌患者,基于治疗前及6个月随访的患者报告呼吸困难,开发并内部验证了同时预测呼吸困难≥3级、2级和≤1级的多项式NTCP模型;该模型结合基线呼吸困难分级、平均肺剂量和化疗治疗,三个等级的AUC分别为0.72、0.76和0.78。
要点
- 多项式NTCP模型同时预测呼吸困难≥3级、2级和≤1级,AUC分别为0.72、0.76和0.78。
- 6个月时呼吸困难较基线恶化≥1级和改善≥1级的发生率分别为31.9%和12.6%。
- 参考模型预测呼吸困难≥2级和≥3级的AUC分别为0.64和0.66,低于多项式模型。
核心结论
- 多项式NTCP模型可高准确度预测呼吸困难分级,给出个体化的呼吸困难症状改善和恶化风险。
研究设计与样本
- 开发并内部验证多项式NTCP模型的研究,纳入182例接受根治性(放化疗)的I-IV期肺癌患者,收集治疗前及6个月随访的患者报告呼吸困难。
主要发现
- 6个月时呼吸困难较基线恶化≥1级和改善≥1级的发生率分别为31.9%和12.6%。
- 呼吸困难≥3级、2级和≤1级的发生率分别为13.7%、20.9%和65.4%。
- 多项式模型结合基线呼吸困难分级和平均肺剂量(风险因素)及化疗治疗(保护因素),预测≥3级、2级和≤1级的AUC(95%CI)分别为0.72(0.65-0.75)、0.76(0.72-0.79)和0.78(0.74-0.80)。
- 参考模型预测呼吸困难≥2级和≥3级的AUC(95%CI)分别为0.64(0.59-0.67)和0.66(0.50-0.70),表现更差。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Dyspnea evolution after radiotherapy for lung cancer is complex with potential symptom deterioration and improvement from baseline. We developed and internally validated a multinomial normal tissue complication probability (NTCP) model predicting dyspnea grade. MATERIALS AND METHODS: Patient-reported dyspnea was collected pre-treatment and during 6 months follow-up for 182 stage I-IV lung cancer patients treated with radical (chemo)radiotherapy. Dyspnea changes (ΔDys) from the baseline grade (Dys0) to the follow-up grade (Dys) were evaluated. A multinomial logistic regression model simultaneously predicting 3 grades of Dys (Dys ≥ 3, Dys = 2 and Dys ≤ 1 (reference level)) was optimized. Reference NTCP models predicting Dys ≥ 2 and Dys ≥ 3 risks irrespective of Dys0 were generated for comparison. Models were shrunken and performance was assessed using optimism-corrected AUC (bootstrapping). RESULTS: Rates of ΔDys ≥ 1 (deterioration) and ΔDys ≤ -1 (improvement) at 6 months were 31.9% and 12.6%. Dys ≥ 3, Dys = 2 and Dys ≤ 1 rates were 13.7%, 20.9% and 65.4%, respectively. The multinomial model (combining the risk factors Dys0 and MLD and the protective factor chemotherapy treatment) predicted Dys ≥ 3, Dys = 2 and Dys ≤ 1 with AUC (95% CI) of 0.72 (0.65-0.75) 0.76 (0.72-0.79) and 0.78 (0.74-0.80), respectively. Reference Dys ≥ 2 and Dys ≥ 3 models showed worse AUC: 0.64 (0.59-0.67) and 0.66 (0.50-0.70), respectively. CONCLUSIONS: Dyspnea grade could be predicted with high accuracy using a multinomial NTCP model, yielding personalized dyspnea symptom improvement and deterioration risks.
引用
- Defraene G, Schuit E, De Ruysscher D, et al. Development and internal validation of a multinomial NTCP model for the severity of acute dyspnea after radiotherapy for lung cancer. Radiother Oncol. 2019. PMID: 31015122. doi:10.1016/j.radonc.2019.03.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。